Chamber and committees

The list of private providers is owned by the UK Government. All providers included on the list must complete or be working towards full United Kingdom Accreditation Service accreditation. If a provider does not complete this or fails the accreditation then they are removed from the list.

Officials continue to work with UK Government to monitor performance of private tests providers. This is done at the private testing provider working group with the Department of Health and Social Care and the devolved administrations, which meet every 2 weeks.

The providers have various standards to meet, which are defined in our regulations and the key performance indicators (KPIs) that are set on turnaround times, customer service and sequencing requirements. Any provider not achieving these standards or engaging in unethical practices are removed from the list.

If individuals are having or have had an issue with a private test provider, they should first report this back to the provider. If they are not satisfied with this then they can submit a complaint here: https://enquiries.test-and-trace.nhs.uk/s/enquiries where the complaint will be investigated.

The amount spent on executive search, advertising and assessment centre costs for the Director General Net Zero role is £26,837. Three candidates were shortlisted and assessed. Two candidates were interviewed by the final panel.

The Centre for Sustainable Delivery (CfSD) (and prior to this the Modernising Patient Pathways Programme within Scottish Government), have supported the rollout of the Digital Dermatology Appointment (DDA) system. This platform allows patients to interact with dermatologists by answering a series of questions and uploading images of their skin condition for the clinician to review. This system is used for both new and return patients. The system was offered for rollout to all Health Boards during COVID and to date is live in five Health Boards, with over 4000 patients having appointments this way.

In addition, the CfSD is actively promoting Active Clinical Referral Triage in Dermatology and encouraging the use of images to support this where this can be done safely. We are currently engaged in a piece of work to understand the use of images in referral pathways across all Scottish Health Boards and the output of this will support key work in 2022 to increase the use of images to support timely access to Dermatology care.

As we set out in our 2021 Programme for Government we will: ‘ deliver the recommendations of the Grouse Moor Management Review Group as a matter of urgency, including the licensing of grouse moors. Licensing or further regulation will cover the key areas identified in the review, including muirburn, wildlife control, the use of medicated grit and wildlife crime .’

The Grouse Moor Management Group chaired by Professor Werritty did not make any recommendations for a system to quantify and publish the number of gamebirds and other quarry species that are shot in Scotland each year and we have no plans to introduce such a system at present.

We are working with NatureScot to develop proposals for a licensing scheme for grouse moor businesses and it is conceivable that such a system might require records of quarry species shot on grouse moors. We will engage closely with relevant stakeholders as those proposals are developed.

Our NHS workforce, across all specialties and care settings, have been remarkable throughout the pandemic. We are deeply grateful for their continued courage, commitment and professionalism.

This year we have made £12 million available to support the wellbeing of our workforce including across primary and social care services.

We are continuing to develop the National Wellbeing Hub, a 24/7 National Wellbeing Helpline, confidential mental health treatment through the Workforce Specialist Service and funding for additional local psychological support. We are also providing further support for practical measures to aid rest and recuperation alongside additional resources including Coaching for Wellbeing and grief and bereavement support.

The Centre for Sustainable Delivery (CfSD) is working with a number of Health Boards to implement the Digital Dermatology app, which allows patients to interact with a clinician at a time convenient to them, without having to attend hospital. This will support dermatology teams in conducting more virtual appointments.

I refer the member to the answer to question S6W-04983 on 23 December 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The pharmacy profession and the provision of pharmaceutical services are highly regulated, overseen by the General Pharmaceutical Council (GPhC). The GPhC's role includes upholding health and safety standards for the pharmacy workforce, as well as for patients.

The Scottish Government regularly meets with Community Pharmacy Scotland, the representative body for pharmacy owners, to discuss a range of topics including workforce issues, including health and wellbeing. This year the Scottish Government has made £12m available to support the wellbeing of the pharmacist workforce. This includes £8m from the NHS Recovery Plan to provide ongoing wellbeing support for the workforce – alongside an extra £4m to provide further support to address winter pressures.

The funding supports the 24/7 National Wellbeing Helpline, our National Wellbeing Hub, Coaching for Wellbeing and the Workforce Specialist Service, alongside tailored psychological interventions for staff, providing individualised wellbeing support focusing on people’s physical and emotional needs.

The Chief Pharmaceutical Officer for Scotland in a joint letter (8 December 2021) with the leaders from the pharmacy sector, including the Royal Pharmaceutical Society (Scotland), has written to all pharmacy teams outlining the range of wellbeing support available to pharmacy teams and encouraging them to access these resources for support when needed.

Following a successful three year pilot, in 2013 the four nations agreed to a 10 year grant to support those affected by the thalidomide drug. Over the last nine years the Scottish Government has issued a total of £11.512 million to the Thalidomide Trust, for distribution to Scottish survivors. A further £1.636 Million is projected for the final year (2022-23), bringing total funding to £13.15 million.

The Scottish Government receives annual funding from the UK Government as part of the Barnett consequentials, however no funding is specifically ‘ring fenced’ for Thalidomide.

Breakdown of Funding:

The Centre for Sustainable Delivery (CfSD) is working collaboratively with the Dermatology AI Consortium championing Community Local Image Centres (CLICs) to improving the capture of images as part of the dermatology pathway. The idea is relatively new and the CLIC model is still in development. The consortium will be developing the operating model and evidence base to show their benefit. CfSD awaits the outcome of this with interest.

It should be noted that the Consortium is also considering other approaches to image acquisition to support dermatology referral – most notably increasing the ease and quality of image acquisition in Primary Care. It is unlikely that a one-size-fits all will suit the varied geography of NHS Boards and therefore CfSD is working to understand the current pathway arrangements in all Boards to support image acquisition prior to Secondary Care.

In Scotland, NHS Forth Valley is hosting a national project to support early diagnosis of skin cancer supported by digitalisation, the use of high-quality images, and machine learning. The project is called 25 by 25 - diagnosing cancer within 25 minutes by 2025. Industry, academics, and NHS are collaborating to rapidly innovate to create AI solutions in skin cancer.

This work is supported through the Scottish Health Industry Partnership and linked to the Health and Social Care and Wellbeing Programme. It takes the form of a number of challenges where partners innovate to find solutions to preparing images, creating AI learning environments, and real world Test Beds to try out new approaches in primary care with Consultant Dermatologist support.